MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Viewer responses to a virtual reality simulation of Parkinson’s disease psychosis

    J.G. Goldman, G.T. Stebbins, D. Fredericks, M. Upchurch (Chicago, IL, USA)

    Objective: To examine the accuracy, effectiveness, and utility of a novel virtual reality (VR) simulation representing symptoms of Parkinson's disease psychosis (PDP). Background: Diagnosing PDP…
  • 2016 International Congress

    Prevalence of depression in Parkinson’s disease patients

    A.M. Weldehana (Addis Ababa, Ethiopia)

    Objective: The objective of this study was to determine the prevalence of depression in PD patients taking into account the different settings and different diagnostic…
  • 2016 International Congress

    Psychiatric manifestations in the initial motor stage of Parkinson’s disease

    I. Stankovic, E. Stefanova, A. Tomic, M. Jecmenica Lukic, V. Markovic, N. Kresojevic, I. Petrovic, M. Svetel, V.S. Kostic (Belgrade, Serbia)

    Objective: To estimate the prevalence and correlates of neuropsychiatric symptoms (NPS) in a cohort of consecutive patients with Parkinson's disease (PD) recruited in the initial…
  • 2016 International Congress

    Neuroleptic medication is associated with a worse health status in the years prior to treatment, but have the potential for normalization

    P. Schmidt, F. Cubillos, T. Simuni, C. Marras, T. Davis, E.C. Nelson, M.S. Okun (Miami, FL, USA)

    Objective: To determine the interval between impact on health-related quality of life (HRQL) and initiation of treatment with neuroleptics in patients with Parkinson's disease (PD)…
  • 2016 International Congress

    Disease-related variables effect on depression and anxiety level in Parkinson’s patients

    T. Uyar, D. Sarikaya Varlik, A. Ercan, O.C. Cenker, I. Gungor Dogan (Rize, Turkey)

    Objective: To evaluate correlations of depression and anxiety levels with motor symptoms, non-motor symptoms and pharmacological factors in Parkinson's disease (PD). Background: Depression and anxiety…
  • 2016 International Congress

    Affective theory of mind in Parkinson’s disease

    A.M. Hammad, S. Ghozy, S.I. El-Jaafary (Cairo, Egypt)

    Objective: The aim of this study is to assess the hypothesis that patients with PD may show difficulties in tasks related to affective theory of…
  • 2016 International Congress

    Anxiety and parkinsonism signs in idiopathic REM sleep behavior disorder

    F. Escudier, R.B. Postuma, P.A. Bourgouin, J. Montplaisir, J.F. Gagnon (Montreal, QC, Canada)

    Objective: To explore the relationship between parkinsonism signs and anxiety symptoms in patients with idiopathic REM sleep behavior disorder (iRBD). Background: A recent study reported…
  • 2016 International Congress

    Factors related to psychotic symptoms in patients with Parkinson’s disease

    B. Tserensodnom (Ulaanbaatar, Mongolia)

    Objective: The aim of this study was to compare clinical characteristics in Parkinson's disease (PD) with psychosis (PDP) versus PD without psychosis (PDnP) and evaluate…
  • 2016 International Congress

    The interactive walkway: Towards assessing gait-environment interactions in a clinical setting

    D.J. Geerse, M. Roerdink, B. Coolen, J. Marinus, J.J. van Hilten (Leiden, Netherlands)

    Objective: To determine the usability of the Interactive Walkway (IWW) for the assessment of walking adaptability. Background: A prerequisite for safe walking is one's ability…
  • 2016 International Congress

    Is Apple Watch a new hope for patients with Parkinson’s disease?

    H. Ohtsubo, H. Iwaki, R. Andou, T. Tsujii, H. Babe, N. Nishikawa, M. Nagai, M. Nomoto (Tohon, Japan)

    Objective: To assess the capability of the smart watch (Apple Watch®) as a simple monitoring tool of motor fluctuation in patients with Parkinson's disease (PD).…
  • « Previous Page
  • 1
  • …
  • 1672
  • 1673
  • 1674
  • 1675
  • 1676
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley